Risperidone: How good is the evidence for efficacy?

25Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This article reviews the published literature evaluating the efficacy of risperidone. The literature includes three multicenter, double-blind studies that compared risperidone, haloperidol, and placebo, as well as three comparisons of risperidone with a standard neuro-leptic. Efficacy of risperidone is reported, but most studies involved chronically hospitalized patients who were relatively refractory; the response to standard neuroleptics was not robust. Also, the reported superiority of risperidone on negative symptoms may be artifactual, since standard neuroleptics, because of extrapyramidal symptoms, can mimic or exacerbate negative symptoms. Finally, risperidone may have an antidepressant effect. It is as yet unclear whether risperidone is as effective as standard neuroleptics for positive schizophrenia symptoms in neuroleptic-responsive patients. © 1997 Oxford University Press.

Cite

CITATION STYLE

APA

Mattes, J. A. (1997). Risperidone: How good is the evidence for efficacy? Schizophrenia Bulletin, 23(1), 155–161. https://doi.org/10.1093/schbul/23.1.155

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free